CBD-rich drug plants, disappearing landrace strains, and the future of cannabis farming.
There is growing interest among medical scientists in the gene-regulating properties of cannabidiol (CBD), the non-psychoactive plant cannabinoid. CBD reduces brain cancer and breast cancer cell proliferation and metastasis by inhibiting the expression of the ID-1 gene.
The Massachusetts-based company Medicinal Genomics has sequenced the entire genome of Cannabis sativa L. The announcement received much attention. But how will it impact research and public health?